Slovakia – Construction work for school buildings – Novostavba SMART základnej školy v záujme inkluzívneho vzdelávania v Plaveckom Štvrtku

Italy – Road construction works – AT1848-26 APPALTO INTEGRATO RIORGANIZZAZIONE OPERA S-369 SS47 DELLA VALSUGANA NEL TRATTO TRA COSTELNUOVO E GRIGNO

Denmark – Construction work – Rammeaftale NO-dig kloakrenovering 2026

Croatia – Plant upgrade work – Rekonstrukcija 110 kV postrojenja u TS 220/110/10 kV Mraclin

Romania – Construction work for buildings relating to leisure, sports, culture, lodging and restaurants – Execuție lucrări pentru obiectivul: „Creșterea atractivității orașului Târgu Neamț și dezvoltarea turismului local prin modernizarea stațiunii «Băile Oglinzi» – Faza I – Construire infrastructură de agrement și revitalizare spații verzi”

Italy – Thermal insulation work – Accordo Quadro interventi di miglioramento sismico e riqualificazione energetica dell'edificio ARTE sito in Genova Via Tofane 92-98

Portugal – Bridge renewal construction work – Empreitada em regime de Conceção e Construção - L. ALGARVE - PONTES GIRANTE DE FARO, TAVIRA E ALMARGEM - SUBSTITUIÇÃO

Expected Outcome: This action will establish a strategic European initiative to develop scalable, modular, and interoperable photonic quantum computing platforms. Proposals for this topic are expected to address and provide credible solutions to at least two major technical roadblocks currently limiting the advancement of photonic quantum computing such as: The lack of deterministic, high-efficiency photonic entanglement and loss-tolerant architectures suitable for fault-tolerant scaling The absence of a standardised, integrated control stack combining photonic hardware, firmware, and system software with reliable benchmarking across platforms Project results are expected to contribute to the following expected outcomes: By 2028, demonstration of a photonic NISQ processor with ≥100 photonic qubits, integrating deterministic single-photon sources, low-loss waveguides, on-chip detectors, and a firmware stack (scheduler, controller, compiler), validated via hardware-agnostic benchmarks and hybrid photonic-HPC applications demonstrating classical-quantum crossover By 2030, delivery of a full-stack, high-connectivity photonic quantum computer, with modular scalability, integrated…

Expected Impact: The action under this topic is expected to achieve the following impacts: Accelerate EU access to more cost-effective interventions in an increasingly ageing population by identifying personalised treatment approaches for elderly-onset immune diseases. Decrease disease risk later in life by defining specific prevention strategies based on ageing biomarkers and risk factors. Halt age-associated disease exacerbation by the identification of predictive and digital biomarkers that can stratify patients for early intervention. Improve quality of life for healthy individuals and patients by preventing further health decline, avoiding escalating care costs, and properly stratifying individuals earlier in the diagnostic pathway. Accelerate adoption of innovative diagnostic, preventative, and therapeutic strategies, strengthening the EU’s position as a healthcare innovator. Evaluate digital biomarker as potential regulatory endpoints in the ultimate goal to develop medicines for ‘healthy ageing’. Integrate fragmented research efforts by bringing together health industry sectors and stakeholders to develop clinical and multi-omics data integration capabilities. Enable new…

Expected Impact: The action under this topic is expected to achieve the following impacts: Faster and more informed decision-making through the use of an AI-driven NAM (AI Foundation Toxicology Model) and increased efficiency through rapid processing of vast amounts of data [1] . Increased consistency and standardisation in a NAM-based approach, specifically an AI model, used by industry in the efficient development, testing and production of safe and effective innovative health technologies, improving industrial competitiveness. Regulatory adoption of a NAM-enabled second species waiver model (AI Foundation Toxicology Model) and weight-of-evidence framework, in line with recommendations and more consistent global decision-making on waiving second species testing. Reduction in animal use, accelerated timelines and lower costs, enhancing the competitiveness of the European health industry through economical and ethical benefits. Improved public health as patients will benefit from safe and effective medicines developed faster using validated NAMs. The action is expected to contribute to the EU Directive (2010/63/EU) [2] on the protection of animals used for scientific purposes and…

Expected Outcome: This action will establish a pan-European open-access testing and experimentation infrastructure for quantum technologies, enabling systematic validation and certification of quantum components and systems. Expected outcomes include: Deployment of distributed quantum testing facilities accessible across Europe, including remote access and standardized test protocols. Provision of certification services aligned with future standardisation efforts, ensuring trust, quality, and interoperability of quantum technologies. Support for SMEs, start-ups, and research institutions in validating quantum components and sub-systems. Strengthening of Europe’s competitiveness by ensuring robust quality assurance mechanisms and accelerating the time-to-market of emerging quantum products. Scope: The proposal should implement the testing-related part of the action plan established under the Framework Partnership Agreement for Qu-Test. The action must include: Expansion and interconnection of open-access testing facilities in multiple Member States, covering a range of quantum technologies (e.g., processors, sensors, photonics, control systems). Development and deployment of…